This activity discusses the drug danazol, a synthetic steroid derivative, in the management of diverse gynecological conditions and hematological disorders. As a therapeutic agent, danazol has proven effective against challenging conditions such as endometriosis, uterine fibroids, and fibrocystic breast disease. Furthermore, its role extends to hematological disorders, notably immune thrombocytopenia (ITP) refractory to conventional treatments and hereditary angioedema. This activity is designed to provide healthcare professionals with a thorough exploration of danazol's clinical applications. The content spans indications, contraindications, pharmacological activity, adverse events, and other essential facets relevant to its therapeutic use.
Copyright © 2024, StatPearls Publishing LLC.